Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
05 2019
Historique:
received: 17 06 2018
revised: 05 01 2019
accepted: 13 01 2019
pubmed: 16 3 2019
medline: 7 3 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

To assess the rate of urinary tract infection (UTI), the characteristics of the bacterial aetiological agents involved, the type and duration of antibiotics used, and the clinical risk factors of UTI in a multi-institutional cohort of patients who had undergone radical cystectomy (RC). The pre- and postoperative characteristics of patients who had undergone open RC at 1 of 3 institutions between 2009 and 2015 were analyzed by means of the patient charts. Patients were classified according to the presence or absence of UTI. Analysis of the severity of UTI was based on the EAU/EAU Section of Infections in Urology (ESIU) classification system. The bacterial aetiological agents and their antibiotic susceptibility were also assessed. Factors predicting postoperative UTI were identified using univariable and multivariable logistic regression analysis. Of 217 patients, 42 (19.4%) had developed postoperative UTI, of whom 50% had urosepsis or uroseptic shock. Multivariable analysis showed continent urinary derivation as the only significant predictor of UTI with an odds ratio of 5.03 (95% confidence interval 2.12-11.9, P < 0.001). The duration of perioperative antibiotic prophylaxis was not associated with an increased risk of UTI. Enterococcus was the most commonly isolated bacteria (25.7%), but this species is not covered by the recommended antibiotic prophylaxis. Patients with continent urinary diversion after RC have a significantly higher risk of developing UTI. Prolonged perioperative administration of antibiotics does not seem to reduce the risk of UTI. Enterococcus as the most commonly isolated bacteria is not covered by most recommended antibiotic prophylaxis regimens. Therefore different antibiotic regimens should be considered for high-risk patients.

Identifiants

pubmed: 30871997
pii: S1078-1439(19)30018-3
doi: 10.1016/j.urolonc.2019.01.017
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

300.e9-300.e15

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Maximilian Haider (M)

Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany. Electronic address: maximilian.haider@ukr.de.

Christian Ladurner (C)

Department of Urology, General Hospital of Bolzano, Bolzano, Italy.

Roman Mayr (R)

Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.

Zafer Tandogdu (Z)

Department of Urology, Northern Institute for Cancer Research, University of Newcastle, Newcastle, United Kingdom.

Hans-Martin Fritsche (HM)

Department of Urology, Chirurgische Klinik München-Bogenhausen, Munich, Germany.

Vincent Fradet (V)

Department of Urology, Laval University, Québec, Canada.

Evi Comploj (E)

Department of Urology, General Hospital of Bolzano, Bolzano, Italy; Department of Research, College of Health Care Professions Claudiana, Bolzano, Italy.

Armin Pycha (A)

Department of Urology, General Hospital of Bolzano, Bolzano, Italy; Sigmund Freud Private University, Medical School, Vienna, Austria.

Francis Lemire (F)

Department of Urology, Laval University, Québec, Canada.

Louis Lacombe (L)

Department of Urology, Laval University, Québec, Canada.

Yves Fradet (Y)

Department of Urology, Laval University, Québec, Canada.

Paul Toren (P)

Department of Urology, Laval University, Québec, Canada.

Michele Lodde (M)

Department of Urology, Laval University, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH